Boston Scientific is committed to advancing clinical safety, efficacy, and procedural efficiency. With recent strategic investments, our robust Electrophysiology portfolio and pipeline are focused on improving the diagnosis, monitoring, and treatment of patients with atrial fibrillation or other heart rhythm disorders.
